Ionis announces retirement of two long-serving directors and appointment of Peter Reikes to board

IONIS PHARMACEUTICALS INC

B. Lynne Parshall and Joseph Wender retiring at end of term in June 2026 after 25+ years on the board.
Peter N. Reikes to rejoin board effective June 4, 2026; he previously served from 2018-2021.
Reikes most recently senior strategy advisor for ARPA-H and senior advisor to FDA.
Both departing directors received Ionis Career Achievement Award; company thanks them.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.